Dataset Open Access
Abbey, Megha; Vedadi, Masoud
<?xml version='1.0' encoding='utf-8'?> <rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:adms="http://www.w3.org/ns/adms#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dct="http://purl.org/dc/terms/" xmlns:dctype="http://purl.org/dc/dcmitype/" xmlns:dcat="http://www.w3.org/ns/dcat#" xmlns:duv="http://www.w3.org/ns/duv#" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:frapo="http://purl.org/cerif/frapo/" xmlns:geo="http://www.w3.org/2003/01/geo/wgs84_pos#" xmlns:gsp="http://www.opengis.net/ont/geosparql#" xmlns:locn="http://www.w3.org/ns/locn#" xmlns:org="http://www.w3.org/ns/org#" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:prov="http://www.w3.org/ns/prov#" xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#" xmlns:schema="http://schema.org/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:vcard="http://www.w3.org/2006/vcard/ns#" xmlns:wdrs="http://www.w3.org/2007/05/powder-s#"> <rdf:Description rdf:about="https://doi.org/10.5281/zenodo.1270383"> <rdf:type rdf:resource="http://www.w3.org/ns/dcat#Dataset"/> <dct:type rdf:resource="http://purl.org/dc/dcmitype/Dataset"/> <dct:identifier rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://doi.org/10.5281/zenodo.1270383</dct:identifier> <foaf:page rdf:resource="https://doi.org/10.5281/zenodo.1270383"/> <dct:creator> <rdf:Description> <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/> <foaf:name>Abbey, Megha</foaf:name> <foaf:givenName>Megha</foaf:givenName> <foaf:familyName>Abbey</foaf:familyName> <org:memberOf> <foaf:Organization> <foaf:name>Structural Genomics Consortium/University of Toronto</foaf:name> </foaf:Organization> </org:memberOf> </rdf:Description> </dct:creator> <dct:creator> <rdf:Description> <rdf:type rdf:resource="http://xmlns.com/foaf/0.1/Agent"/> <foaf:name>Vedadi, Masoud</foaf:name> <foaf:givenName>Masoud</foaf:givenName> <foaf:familyName>Vedadi</foaf:familyName> <org:memberOf> <foaf:Organization> <foaf:name>Structural Genomics Consortium/University of Toronto</foaf:name> </foaf:Organization> </org:memberOf> </rdf:Description> </dct:creator> <dct:title>The process of HDAC11 Assay Development: linearity and Km calculation</dct:title> <dct:publisher> <foaf:Agent> <foaf:name>Zenodo</foaf:name> </foaf:Agent> </dct:publisher> <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#gYear">2018</dct:issued> <dcat:keyword>HDAC11</dcat:keyword> <dcat:keyword>linearity</dcat:keyword> <dcat:keyword>enzyme kinetics</dcat:keyword> <dcat:keyword>burst</dcat:keyword> <dcat:keyword>burst kinetics</dcat:keyword> <dcat:keyword>boc-lys-TFA-AMC</dcat:keyword> <dct:issued rdf:datatype="http://www.w3.org/2001/XMLSchema#date">2018-06-04</dct:issued> <owl:sameAs rdf:resource="https://zenodo.org/record/1270383"/> <adms:identifier> <adms:Identifier> <skos:notation rdf:datatype="http://www.w3.org/2001/XMLSchema#anyURI">https://zenodo.org/record/1270383</skos:notation> <adms:schemeAgency>url</adms:schemeAgency> </adms:Identifier> </adms:identifier> <dct:isVersionOf rdf:resource="https://doi.org/10.5281/zenodo.1270382"/> <dct:isPartOf rdf:resource="https://zenodo.org/communities/openlabnotebooks"/> <dct:isPartOf rdf:resource="https://zenodo.org/communities/sgc-opennotebook"/> <dct:description><p>With previously optimized conditions, the linearity range for HDAC11 was obtained and the Km for the substrate was calculated.</p> <p>&nbsp;</p> <p><strong>Note: </strong>1. In the assay buffer, BSA conc. is 0.5 mg/ml (instead of 0.5%).</p> <p>&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; 2. In the 7.5 ul developer solution, 40 uM of TSA (Trichostatin A) is also included.</p></dct:description> <dct:description>The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.</dct:description> <dct:accessRights rdf:resource="http://publications.europa.eu/resource/authority/access-right/PUBLIC"/> <dct:accessRights> <dct:RightsStatement rdf:about="info:eu-repo/semantics/openAccess"> <rdfs:label>Open Access</rdfs:label> </dct:RightsStatement> </dct:accessRights> <dcat:distribution> <dcat:Distribution> <dct:license rdf:resource="https://creativecommons.org/licenses/by/4.0/legalcode"/> <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.1270383"/> </dcat:Distribution> </dcat:distribution> <dcat:distribution> <dcat:Distribution> <dcat:accessURL rdf:resource="https://doi.org/10.5281/zenodo.1270383"/> <dcat:byteSize>237592</dcat:byteSize> <dcat:downloadURL rdf:resource="https://zenodo.org/record/1270383/files/4june2018-HDAC11 assay deve process-linearity-Km.pdf"/> <dcat:mediaType>application/pdf</dcat:mediaType> </dcat:Distribution> </dcat:distribution> </rdf:Description> </rdf:RDF>
All versions | This version | |
---|---|---|
Views | 123 | 123 |
Downloads | 48 | 48 |
Data volume | 11.4 MB | 11.4 MB |
Unique views | 102 | 102 |
Unique downloads | 45 | 45 |